178 related articles for article (PubMed ID: 22904136)
21. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations.
ASCUS-LSIL Traige Study (ALTS) Group
Am J Obstet Gynecol; 2003 Jun; 188(6):1393-400. PubMed ID: 12824968
[TBL] [Abstract][Full Text] [Related]
22. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.
Vale DB; Westin MC; Zeferino LC
Cancer Cytopathol; 2013 Oct; 121(10):576-81. PubMed ID: 23765869
[TBL] [Abstract][Full Text] [Related]
23. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
24. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan.
Fujiwara H; Suzuki M; Morisawa H; Sayama M; Kimura K
Asian Pac J Cancer Prev; 2019 Jan; 20(1):81-85. PubMed ID: 30678384
[TBL] [Abstract][Full Text] [Related]
26. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap revisited and the treatment of risk.
Herbert A; Smith JA
Cytopathology; 1999 Jun; 10(3):161-70. PubMed ID: 10390064
[TBL] [Abstract][Full Text] [Related]
27. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2.
Castle PE; Schiffman M; Wheeler CM; Solomon D
Obstet Gynecol; 2009 Jan; 113(1):18-25. PubMed ID: 19104355
[TBL] [Abstract][Full Text] [Related]
28. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
[TBL] [Abstract][Full Text] [Related]
29. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation.
Lonky NM; Felix JC; Naidu YM; Wolde-Tsadik G
Obstet Gynecol; 2003 Mar; 101(3):481-9. PubMed ID: 12636951
[TBL] [Abstract][Full Text] [Related]
30. Management of abnormal cervical cytology screening in adolescent and young women in a canadian colposcopy centre: a descriptive analysis.
Bouchard-Fortier G; Paszat L; Murphy KJ
J Obstet Gynaecol Can; 2013 Feb; 35(2):149-55. PubMed ID: 23470065
[TBL] [Abstract][Full Text] [Related]
31. The incidence of cervical intraepithelial neoplasia in a population of pregnant women with an abnormal cytology.
Pruski D; Malkowska-Walczak B; Paluszkiewicz A; Kędzia W
Ginekol Pol; 2017; 88(1):20-23. PubMed ID: 28157250
[TBL] [Abstract][Full Text] [Related]
32. [Prevalence of high-risk human papillomavirus and incidence of cervical intraepithelial neoplasia in female populations in Shenzhen, Guangdong Province].
Wu RF; Liu ZH; Zhou QZ; Wulan N; Wang Q; Li Q; Li N; Liu ZH; Shi JF; Li RZ; Zhang CH; Zhou YQ; Liu B; Weng LM; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):90-5. PubMed ID: 20236596
[TBL] [Abstract][Full Text] [Related]
33. Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial.
Elfström KM; Smelov V; Johansson AL; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
Int J Cancer; 2015 Jan; 136(2):350-9. PubMed ID: 24842156
[TBL] [Abstract][Full Text] [Related]
34. Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
Tracht JM; Davis AD; Fasciano DN; Eltoum IA
Cancer Cytopathol; 2017 Oct; 125(10):795-805. PubMed ID: 28817235
[TBL] [Abstract][Full Text] [Related]
35. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology.
Zhang S; Saito M; Yamada S; Sakamoto J; Takakura M; Takagi H; Sasagawa T
J Med Virol; 2020 Mar; 92(3):364-371. PubMed ID: 31642536
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
[TBL] [Abstract][Full Text] [Related]
38. Different detectability of high-risk HPV in smears from incident and prevalent high-grade squamous intraepithelial lesions of the cervix.
Schneider A; Zahm DM; Greinke C; Kirchmayr R; Nindl I
Gynecol Oncol; 1997 Jun; 65(3):399-404. PubMed ID: 9190964
[TBL] [Abstract][Full Text] [Related]
39. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
40. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]